Sonoma Pharmaceuticals (SNOA) Asset Utilization Ratio (2011 - 2026)

Sonoma Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 1.42 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 35.58% year-over-year to 1.42 in Q1 2026; TTM through Mar 2026 was 1.42, a 35.58% increase from a year earlier, with the FY2026 full-year figure at 1.41, up 40.54% from the prior year.
• Asset Utilization Ratio improved to 1.42 in Q1 2026 per SNOA's latest filing, from 1.29 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.42 in Q1 2026 and bottomed at 0.66 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.88 (2023), against an average of 0.95.
• Biggest YoY gain for Asset Utilization Ratio was 36.35% in 2022; the steepest drop was 41.04% in 2022.
• Year by year, Asset Utilization Ratio stood at 0.87 in 2022, then advanced by 0.25% to 0.87 in 2023, then increased by 17.24% to 1.02 in 2024, then grew by 26.25% to 1.29 in 2025, then increased by 9.78% to 1.42 in 2026.
• Per Business Quant, the three latest SNOA Asset Utilization Ratio figures stand at 1.42 (Q1 2026), 1.29 (Q4 2025), and 1.19 (Q3 2025).